Literature DB >> 9785214

Discordant detection of human cytomegalovirus DNA from peripheral blood mononuclear cells, granulocytes and plasma: correlation to viremia and HCMV infection.

K Hamprecht1, M Steinmassl, H Einsele, G Jahn.   

Abstract

BACKGROUND: There exist only few data about the HCMV infection of single positive leukocyte subtypes in immunosuppressed patients. Most reports describe HCMV coinfection of cells of the myelomonocytic line or even T- and B-cell populations. Correlation of positive PCR findings from two major leukocyte fractions and plasma to viremia and HCMV infection in general should contribute to select suitable sources of HCMV DNA for diagnostic purposes.
OBJECTIVE: The diagnostic value of qualitative leukoDNAemia of simultaneously isolated peripheral blood mononuclear cells (PBMC), granulocytes as well as plasmaDNAemia was evaluated by comparing the positive results of nested PCR from blood with virus isolation either from leukocytes or from any other sources, with serology and the clinical status of immunosuppressed patients. STUDY
DESIGN: PBMC, granulocytes and plasma were prepared of a total of 220 blood samples of 75 immunosuppressed patients with clinically suspected primary or recurrent HCMV infection. In a collective of 35 patients consisting mainly of recipients of marrow or solid organ transplants positive results of leuko- or plasmaDNAemia were correlated with data from HCMV screening and the clinical status. For standardization, HCMV IE Exon 4 DNA was amplified from 100 ng cellular DNA of each leukocyte population. Cross contamination can be excluded. DNA from plasma was extracted by phenol/chloroform. Using this experimental design, HCMV DNA was not detectable in PBMC, granulocytes and plasma of 23 healthy HCMV seropositive blood donors.
RESULTS: Leukocyte separation in a collective of 30 patients with positive leukoDNAemia revealed in only 12 cases (40%) double infection of PBMC and granulocytes. In the majority of cases (18 patients, 60%) however, HCMV DNA was detectable in only one leukocyte fraction, either in PBMC or granulocytes. LeukoDNAemia did not correlate to viremia. HCMV DNA amplified from plasma was shown to be cell free. Infectious virus from plasma was not isolated. The predictive value of qualitative nested PCR from blood to detect HCMV infection was high for plasma and decreased in the following sequence: plasma (0.92) > PBMC (0.83) > granulocytes (0.65).
CONCLUSIONS: Qualitative nPCR from plasma and PBMC seems to be sufficient to detect (an ongoing) HCMV infection of immunosuppressed patients. However, the rate of single positive leukocyte fractions is approximately 60%. Therefore, viral leukoDNAemia in 40% of cases seems to be restricted to either PBMC or granulocytes. For diagnostic purposes the whole leukocyte population should be used for PCR analysis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9785214     DOI: 10.1016/s1386-6532(98)00046-4

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  10 in total

Review 1.  Management of cytomegalovirus infection in solid organ transplantation.

Authors:  Camille N Kotton
Journal:  Nat Rev Nephrol       Date:  2010-10-26       Impact factor: 28.314

2.  Cytomegalovirus infection in severe ulcerative colitis patients undergoing continuous intravenous cyclosporine treatment in Japan.

Authors:  Masaaki Minami; Michio Ohta; Teruko Ohkura; Takafumi Ando; Naoki Ohmiya; Yasumasa Niwa; Hidemi Goto
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

Review 3.  New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.

Authors:  I G Sia; R Patel
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

4.  Human cytomegalovirus infection of a severe-burn patient: evidence for productive self-limited viral replication in blood and lung.

Authors:  Klaus Hamprecht; Mathias Pfau; Hans-Eberhard Schaller; Gerhard Jahn; Jaap M Middeldorp; Hans-Oliver Rennekampff
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

5.  Determining the prevalence of cytomegalovirus infection in a cohort of preterm infants.

Authors:  Mitchell M Pitlick; Kristin Orr; Allison M Momany; Erin L McDonald; Jeffrey C Murray; Kelli K Ryckman
Journal:  J Neonatal Perinatal Med       Date:  2015

6.  Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis.

Authors:  Alexandra Heininger; Helene Haeberle; Imma Fischer; Robert Beck; Reimer Riessen; Frank Rohde; Christoph Meisner; Gerhard Jahn; Alfred Koenigsrainer; Klaus Unertl; Klaus Hamprecht
Journal:  Crit Care       Date:  2011-03-01       Impact factor: 9.097

7.  Evaluation of DNA extraction from granulocytes discarded in the separation medium after isolation of peripheral blood mononuclear cells and plasma from whole blood.

Authors:  Janná R Murray; Mangalathu S Rajeevan
Journal:  BMC Res Notes       Date:  2013-11-01

8.  Human cytomegalovirus glycoprotein polymorphisms and increasing viral load in AIDS patients.

Authors:  Xiao-Jing Jiang; Jun Zhang; Yong Xiong; Gerhard Jahn; Hai-Rong Xiong; Zhan-Qiu Yang; Yuan-Yuan Liu
Journal:  PLoS One       Date:  2017-05-03       Impact factor: 3.240

9.  Neutralizing Antibodies Limit Cell-Associated Spread of Human Cytomegalovirus in Epithelial Cells and Fibroblasts.

Authors:  Nina Reuter; Barbara Kropff; William J Britt; Michael Mach; Marco Thomas
Journal:  Viruses       Date:  2022-01-28       Impact factor: 5.048

10.  Reactivation of multiple viruses in patients with sepsis.

Authors:  Andrew H Walton; Jared T Muenzer; David Rasche; Jonathan S Boomer; Bryan Sato; Bernard H Brownstein; Alexandre Pachot; Terrence L Brooks; Elena Deych; William D Shannon; Jonathan M Green; Gregory A Storch; Richard S Hotchkiss
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.